Partial loss of genes might open therapeutic window
Related Experiment Video
Updated: Mar 6, 2026
09:37
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
2.2K
1Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, United States.
Elife
|March 18, 2017
Abstract:
The loss of genes that encode RNA splicing factors weakens cancer cells in a way that could be exploited by new approaches to treatment.
Insights
Loss of RNA splicing factor genes weakens cancer cells, offering new therapeutic targets. This vulnerability in cancer cells presents opportunities for novel treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- RNA splicing is crucial for gene expression and cellular function.
- Alterations in RNA splicing are implicated in various cancers.
- Cancer cells often exhibit unique dependencies on specific cellular processes.
Purpose of the Study:
- To investigate the consequences of RNA splicing factor gene loss in cancer.
- To identify potential therapeutic vulnerabilities arising from impaired RNA splicing.
Main Methods:
- Utilized genetic screening to identify essential genes in cancer cells.
- Analyzed the impact of RNA splicing factor gene depletion on cancer cell viability.
- Examined downstream effects on gene expression and cellular pathways.
Main Results:
- Depletion of specific RNA splicing factor genes significantly impaired cancer cell growth.
- Loss of these factors created a dependency that could be targeted.
- Identified molecular mechanisms underlying this cancer cell weakness.
Conclusions:
- Genes encoding RNA splicing factors are critical for cancer cell survival.
- Targeting RNA splicing represents a promising strategy for cancer therapy.
- Exploiting these vulnerabilities could lead to the development of novel anti-cancer treatments.
Keywords:
CYCLOPS genesSF3B1cancer biologycancer therapeuticscopy number alterationshumanhuman biologymedicinemousespliceosometarget identification and validationMore Related Videos
Related Concept Videos
01:12Loss of Tumor Suppressor Gene Functions
6.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
01:29Pharmacogenomics: Identification of New Drug Targets
55
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
55
00:59Gene Therapy
27.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.8K
01:16In-vitro Mutagenesis
17.4K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.4K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
56
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56